Interferon beta-1b

Red

Brand Name(s):Betaferon, Extavia

Indication:Multiple sclerosis

Rationale:1,2

Considered:Mar-07

Review Date:Jan-25

Comments:
NICE CG186 Management of MS in Primary & Secondary Care:
http://www.nice.org.uk/guidance/cg186/resources/guidance-multiple-sclerosis-pdf
Oct 2014
…………………………
MHRA Drug Safety Alert:reports of thrombotic microangiopathy (including fatal cases) and nephrotic syndrome linked to interferon beta treatment. Further information at:http://www.mhra.gov.uk/home/groups/comms-ic/documents/drugsafetymessage/con465929.pdf
September 2014
…………………………
MHRA Drug Safety Update – thrombotic microangiopathy, details at:http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON355481
December 2013